Matches 1 - 50 out of 149 1 2 3 >


Match Document Document Title
US20140051693 TREATMENT FOR CEREBRAL PALSY IMPAIRED SPEECH IN CHILDREN  
Cerebral palsy impaired speech in children and adolescents are effectively treated by administration of a psychostimulant. Low doses of the psychostimulant significantly increases the percentage...
US20150209327 METHODS FOR THE TREATMENT OF OBESITY USING APREMILAST  
Methods of treating, managing or preventing obesity and overweight are disclosed. Specific methods encompass the administration of apremilast, alone or in combination with additional active agents...
US20130195997 FUNGICIDAL MIXTURES  
The invention relates to a method of controlling fungi and spores and to compositions suitable for this purpose and their use. The compositions according to the invention comprise trifloxystrobin,...
US20140235593 SUBSTITUTED 2-ALKYL-1-OXO-N-PHENYL-3-HETEROARYL-1,2,3,4-TETRAHYDROISOQUINOLINE-4-CARBOXAMIDES FOR ANTIMALARIAL THERAPIES  
In one aspect, the invention relates to novel substituted 2-alkyl-1-oxo-N-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoqui noline-4-carboxamides; synthetic methods for making the compounds;...
US20100152179 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS  
A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention...
US20110190285 METHODS OF TREATING A BOTULINUM TOXIN RELATED CONDITION IN A SUBJECT  
The present invention provides methods of treating a botulinum toxin related condition in a subject. In certain embodiments, the methods involve administering a compound of the following formulas:...
US20120276182 METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS  
The present invention relates to methods for treating and completely curing fungal, yeast, and/or mold infections in human subjects comprising topically administering to a human subject in need...
US20140155369 PREVENTIVES/REMEDIES FOR STRESS URINARY INCONTINENCE AND METHOD OF SCREENING THE SAME  
An agent for the prophylaxis or treatment of stress urinary incontinence, which contains a substance that activates a serotonin 5-HT2C receptor, an agent for the prophylaxis or treatment of stress...
US20150216835 METHODS OF TREATING AN OVERWEIGHT OR OBESE SUBJECT  
The invention herein generally relates to pharmaceutical formulations and methods of treating an overweight or obese subject, and overweight- or obesity-related conditions.
US20120309753 METHOD OF DISSOLVING ANTIFUNGAL AGENT, AND COMPOSITIONS WITH A HIGH CONCENTRATION OF ANTIFUNGAL AGENT, SUITABLE FOR APPLICATION TO THE NAIL  
A pharmaceutical composition is described which includes: an antifungal agent from the class of the allylamines or the morpholines, at a concentration of at least 5%; a ternary solvent system...
US20120149693 THERAPEUTIC COMPOUNDS  
The invention relates to protein binding interacting/binding compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for...
US20090318451 MORPHOLINE DOPAMINE AGONISTS FOR THE TREATMENT OF PAIN  
The present invention relates to use of a compound of formula (I), (Ia), or (Ib): wherein A, B, Z, R1 and R2 have the meanings given in the specification, as a medicament for the treatment of a...
US20150133297 NEW ANTIFUNGAL COMPOSITIONS  
The present invention relates to new antifungal compositions and their use in the treatment of agricultural products.
US20100179115 USE OF A GLUCOCORTICOID RECEPTOR II ANTAGONIST TO TREAT DEPRESSION IN PATIENTS TAKING IL-2  
The invention pertains to the discovery that type II glucocorticoid receptor antagonists can be used in methods for reversing or inhibiting the symptoms of depression in patients receiving...
US20120165325 Stable forms of N-(2,6-Dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide  
Polymorphic forms of N-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyra mide are provided together with a process for the manufacture of said compound.
US20110046128 NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS  
A series of novel compounds showing anticonvulsant, chemical countermeasure(s), and analgesic activities is described. Such pharmaceutically active compounds may also show utility in the treatment...
US20060275237 Skin care compositions containing idebenone  
A stable skin care composition, comprising an effective amount of idebenone, at least one additional skin care active, and a dermatologically acceptable carrier.
US20140329811 Methods of Modulating Cell Proliferation and Cyst Formation in Polycystic Kidney and Liver Diseases  
The present invention provides a method for preferentially reducing the proliferation of cystic epithelial cells in the kidney or bile duct in a mammal in need thereof by administering a 20-HETE...
US20080268038 Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength  
Provided are compositions and methods for increasing diet induced thermogenesis. Typically, the compositions are comprised of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine,...
US20130281452 SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS  
Substituted 4-aminobenzamides, pharmaceutical compositions containing these compounds and also methods of using these compounds in the treatment and/or prophylaxis of pain and further diseases...
US20150126436 METHOD OF TREATING SCEDOSPORIUM SPP. INFECTION  
The present invention provides a method of treatment of Scedosporium spp. infection in an animal comprising the step of administering to the infected animal an effective amount of a compound of...
US20090118267 INDANES  
Compounds of the formula (I), in which R1, R2, R3, R4, and q have the meanings indicated in claim 1, can be employed, inter alia, for the treatment of tumours.
US20110160200 Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension  
The invention relates to methods of treating, preventing or delaying the onset or development of pulmonary hypertension using hydroxyl donors or pharmaceutically acceptable salts thereof. The...
US20120064052 Hydrolysis Resistant Organomodified Trisiloxane Surfactants  
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide...
US20100311734 Spiro Compounds Useful as Antagonists of the H1 Receptor  
The invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, for treating diseases and conditions of the central nervous system (CNS), in particular sleep disorders.
US20120064180 USE OF NO AND NO DONORS FOR TERMINATING DORMANCY IN INVERTEBRATES  
The present invention relates to a method for terminating dormancy in an invertebrate, wherein said invertebrate is brought in contact with nitric oxide and/or a nitric oxide donor. The method can...
US20090075994 DEUTERIUM-ENRICHED RADAFAXINE  
The present application describes deuterium-enriched radafaxine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
US20140179518 Pesticidal Mixtures Comprising Cyanosulfoximine Compounds  
The present invention relates to pesticidal mixtures comprising as active components 1) at least one cyanosulfoximine compound I of the formula I wherein R1, R2 and G are defined as in the...
US20110159107 Pesticidal Mixtures Comprising Isoxazoline Compounds II  
The present invention relates to pesticidal mixtures comprising as active components 1) at least one isoxazoline compound I of the formula I wherein R1, R2, R3, R4, R5 and A are defined as in the...
US20110081426 AMINOTHIAZOLE MODULATORS OF BETA-3-ADRENORECEPTOR  
The present invention relates to new aminothiazole modulators of beta-3-adrenoreceptor activity, pharmaceutical compositions thereof, and methods of use thereof.
US20140100224 NEUROTROPHIN MIMETICS AND USES THEREOF  
The present application is related to compounds which are novel neurotrophin mimetics. The application also discloses the treatment of disorders associated with p75 expression, such as degradation...
US20130150357 HYDROXYBUPROPION ANALOGUES FOR TREATING DRUG DEPENDENCE  
The invention provides hydroxybupropion analogues capable of inhibiting the reuptake of one or more monoamines and/or acting as antagonists at nicotinic acetylcholine receptors. The compounds may...
US20100222303 REVERSE-TURN MIMETICS AND METHOD RELATING THERETO  
Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins as well as their prodrugs are disclosed. Such...
US20130203752 PHENYLMORPHOLINES AND ANALOGUES THEREOF  
Provided herein are compounds and prodrugs and methods of preparation of compounds and prodrugs that are capable of functioning as releasers and/or uptake inhibitors of one or more monoamine...
US20080119463 4-Anilino-3-quinolinecarbonitriles for the treatment of acute myelogenous leukemia (AML)  
The claimed invention is directed to a method of treating, inhibiting, or preventing acute myelogenous leukemia, also called acute myeloid leukemia (AML), using 4-anilino-3-quinolinecarbonitriles.
US20120322799 DEUTERATED COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISEASES  
The present application is related to deuterated compounds which are novel neurotrophin mimetics. The application also discloses the treatment of disorders involving degradation or dysfunction of...
US20070299055 COMBINATION OF SEDATIVE AND A NEUROTRANSMITTER MODULATOR, AND METHODS FOR IMPROVING SLEEP QUALITY AND TREATING DEPRESSION  
One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used to treat, e.g., insomnia and/or depression. The...
US20080306030 Use of a TRPM5 Inhibitor to Regulate Insulin and GLP-1 Release  
The present invention is directed to methods of enhancing insulin release, GLP-1 release, and insulin sensitivity, methods of increasing insulin gene expression, methods of decreasing gastric...
US20120087913 INDUCTION OF TUMOR HYPOXIA FOR CANCER THERAPY  
Methods and compositions for enhancing the ability of hypoxia-activated bioreductive agents to kill tumor cells within solid tumors are provided. Local regions of hypoxia are created within a...
US20090105238 Compounds and Relative use for the Control of Phytopathogens  
Amphoteric compounds are described, having a zwitterionic structure of the betainic type having general formula (I) and their use for the control of phytopathogen fungi and/or the mitigation of...
US20150231048 Method of Maintaining Oral Health in Animals  
Use of a compound having the formula (I) in the manufacture of a medicament for the prevention or treatment of a diseased caused by oral bacterial in an animal Formula (I); wherein R1 is a...
US20110171143 Method of maintaining oral health in animals  
Use of a compound having the formula (I) in the manufacture of a medicament for the prevention or treatment of a disease caused by oral bacteria in an animal wherein R1 is a straight or branched...
US20120088665 FUNGICIDAL MIXTURES  
The present invention relates to fungicidal mixtures comprising, as active components, 1) sulfur-containing triazole compounds I as described in the application, and2) a fungicidal compound II,...
US20070259865 Agent for Promoting the Recovery from Dysfunction After the Onset of Central Neurological Disease  
It is intended to provide a novel agent for promoting the recovery from dysfunction after the onset of a central neurological disease or an agent for enhancing and/or promoting the effect of...
US20070197523 CALCIUM CHANNEL ANTAGONISTS  
The present invention provides novel calcium channel antagonists, and methods of treating disease sates using the novel antagonists.
US20080249088 Topical Delivery of Antifungal Drugs  
A topical formula for treatment of antifungal infections of the skin and nails comprises: (a) a therapeutically effective amount of a benzylamine or morpholine antifungal compound; (b) an...
US20100203103 THERAPEUTIC COMPOSITIONS FOR TREATMENT OF INFLAMMATION OF OCULAR AND ADNEXAL TISSUES  
The present invention comprises a composition with means to inhibit the function of the inflammatory cytokine IL-1 and methods for using this composition to treat inflammatory disease of ocular...
US20120214808 Aryl Urea Derivatives for Treating Obesity  
A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in...
US20140286931 BIPHENYL-3-CARBOXYLIC ACID MODULATORS OF BETA-3-ADRENORECEPTOR  
The present invention relates to new biphenyl-3-carboxylic acid modulators of beta-3-adrenoceptor activity, pharmaceutical compositions thereof, and methods of use thereof.
US20080057134 Antifungal compositions and method  
Efficacious antifungal compositions are prepared comprising a mixture of a traditional fungicide and an ion-exchange type antimicrobial agent.

Matches 1 - 50 out of 149 1 2 3 >